{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:42:28Z","timestamp":1764020548370,"version":"3.37.3"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leo Greece"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TH Open"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Cancer-associated thrombosis (CAT) is the second cause of mortality after cancer itself. CAT is underestimated as a health challenge among oncologists, whereas the levels of awareness among patients and the public have not been systematically assessed and followed in the European Union countries.<\/jats:p><jats:p>\n          Aim\u2003The Prospective Risk Assessment and Management of Patient with CAT (ROADMAP-CAT) Awareness study is an investigator-initiated, descriptive and nonexperimental study with a cross-sectional design and it explores CAT risk awareness among cancer patients and the general public in Greece to provide an impetus for health policy interventions and a benchmark against which impact of any future interventions may be assessed.<\/jats:p><jats:p>\n          Methods\u2003A total of 1,003 participants aged above 18 years were contacted by phone after random selection from the national telephone catalogue. Participation was voluntary and completely anonymous, and a structured questionnaire was used to elicit responses. Data were analyzed using IBM SPSS version 25.<\/jats:p><jats:p>\n          Results\u2003Among respondents, almost one-third (32.3%) reported CAT awareness, while only one in five (21.7%) were aware of the signs and symptoms of venous thromboembolism (VTE). Among patients with a personal history of cancer or of VTE, 47 and 58%, respectively, were aware of CAT risk. Of those aware of the association, 35.2% identified their treating physician as the main source of information. The level of awareness did not significantly differ by responders' demographics.<\/jats:p><jats:p>\n          Conclusion\u2003The ROADMAP-CAT Awareness study revealed very low levels of awareness on CAT and VTE risk both among the general public and cancer patients in Greece. Awareness of the signs and symptoms of VTE was also particularly low. Treating physicians are not actively engaging in educating their patients about CAT. Public awareness of the increased risk of VTE among cancer patients is critical to prevent and diagnose the disease early. It is imperative that a structured campaign supports medical professionals to take the time to increase awareness and educate their patients on this matter if to improve morbidity and mortality of cancer patients.<\/jats:p>","DOI":"10.1055\/a-1742-0465","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T23:57:40Z","timestamp":1642463860000},"page":"e89-e95","source":"Crossref","is-referenced-by-count":6,"title":["Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study"],"prefix":"10.1055","volume":"06","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-9444","authenticated-orcid":false,"given":"Kyriakos","family":"Souliotis","sequence":"additional","affiliation":[{"name":"Department of Social and Education Policy, University of Peloponnese, Corinth, Greece"},{"name":"Research Department, Health Policy Institute, Maroussi, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Golna","sequence":"additional","affiliation":[{"name":"Policy Change Department, Innowth, Larnaca, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Nikolaidi","sequence":"additional","affiliation":[{"name":"Research Department, Health Policy Institute, Maroussi, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick V.","family":"Dreden","sequence":"additional","affiliation":[{"name":"Sorbonne University, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Unit 938, Research Group Cancer, Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Canc\u00e9rologie, Paris, France"},{"name":"Department of Clinical Research, Diagnostica Stago, Gennevilliers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Vatheia","sequence":"additional","affiliation":[{"name":"Research Department, Health Policy Institute, Maroussi, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2316-6348","authenticated-orcid":false,"given":"Grigoris T.","family":"Gerotziafas","sequence":"additional","affiliation":[{"name":"Sorbonne University, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Unit 938, Research Group Cancer, Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), Institut Universitaire de Canc\u00e9rologie, Paris, France"},{"name":"Thrombosis Center, Tenon-Saint Antoine, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris (APHP), France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"A A Khorana","year":"2007","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood.V124.21.4829.4829","article-title":"Mortality from cancer-associated venous thromboembolism","volume":"124","author":"H Michael","year":"2014","journal-title":"Blood"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","article-title":"Epidemiology of cancer-related venous thromboembolism","volume":"22","author":"T Wun","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2019.08.013","article-title":"Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014)","volume":"182","author":"O A Almohammed","year":"2019","journal-title":"Thromb Res"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.breast.2013.04.018","article-title":"Risk factors associated with venous thromboembolism in 49,028 mastectomy patients","volume":"22","author":"B H Tran","year":"2013","journal-title":"Breast"},{"issue":"25","key":"ref6","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis","volume":"29","author":"R A Moore","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"P Prandoni","year":"2002","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"S R Kahn","year":"2012","journal-title":"Chest"},{"issue":"02","key":"ref12","first-page":"111","article-title":"Prevention and treatment of venous thromboembolism\u2013International Consensus Statement","volume":"32","author":"A N Nicolaides","year":"2013","journal-title":"Int Angiol"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jth.12071","article-title":"International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer","volume":"11","author":"P Debourdeau","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"D Farge","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH","volume":"17","author":"T F Wang","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"S 06","key":"ref16","doi-asserted-by":"crossref","first-page":"vi85","DOI":"10.1093\/annonc\/mdr392","article-title":"Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines","volume":"22","author":"M Mandal\u00e0","year":"2011","journal-title":"Ann Oncol"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"N S Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jvn.2008.09.005","article-title":"Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients","volume":"26","author":"S Le Sage","year":"2008","journal-title":"J Vasc Nurs"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/jth.13483","article-title":"Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis","volume":"14","author":"I Mah\u00e9","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"J Cohen","year":"1992","journal-title":"Psychol Bull"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ejsp.2752","article-title":"Empirically derived guidelines for interpreting effect size in social psychology","volume":"51","author":"A Lovakov","year":"2021","journal-title":"Eur J Soc Psychol"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"F Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmv.2014.03.001","article-title":"Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study","volume":"39","author":"M A Sevestre","year":"2014","journal-title":"J Mal Vasc"},{"issue":"09","key":"ref24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.13378","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer","volume":"14","author":"A S Mansfield","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jvn.2012.07.001","article-title":"Awareness of patients who undergo cesarean section about venous thromboembolism prophylaxis","volume":"31","author":"K H Alzoubi","year":"2013","journal-title":"J Vasc Nurs"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11239-015-1224-4","article-title":"Venous thromboembolism: patient awareness and education in the pre-operative assessment clinic","volume":"41","author":"A Haymes","year":"2016","journal-title":"J Thromb Thrombolysis"}],"container-title":["TH Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1742-0465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T14:16:45Z","timestamp":1660141005000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1742-0465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":23,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,4,27]]},"published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1742-0465","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2512-9465"],"issn-type":[{"type":"electronic","value":"2512-9465"}],"subject":[],"published-other":{"date-parts":[[2022,1,17]]},"published":{"date-parts":[[2022,1,17]]}}}